# SHAPE (NCT01658930)

> Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: low-risk early-stage cervical cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01658930
- Phase: NA
- Status: COMPLETED
- Sponsor: Canadian Cancer Trials Group
- Conditions: Cervical Cancer
- Interventions: Radical Hysterectomy + pelvic lymph node dissection; Simple hysterectomy + pelvic lymph node dissection
- Enrollment: 700
- Primary outcome: Pelvic Recurrence Rate at 3 Years

## Indexed commentary on SHAPE so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=shape-nct01658930